Non-life insurers keep launching niche lifestyle products — but few are sticking

Water sports insurance, running insurance, pet insurance — non-life insurers have been rolling out products targeting everyday moments, but getting them to take hold in the market is proving harder than ever. A saturated market, increasingly stringent product reviews and a tough sales environment are deepening the industry's headache over new product development.

According to insurance industry sources Friday, non-life insurers have recently launched a string of lifestyle-focused products aimed at catching consumers' attention. Products introduced since last year alone span water sports and surfing insurance, running insurance, screen golf insurance, Greater Seoul subway delay insurance and pet insurance.

The problem is that these efforts rarely translate into results. Low-premium products generate little revenue given their small scale, and enrollment numbers have been thin — leading industry observers to question whether the trend carries any real significance.

The first reason new products have become so difficult is that the domestic insurance market is approaching saturation, with most common risks already covered by existing products. Within traditional disease coverage, the industry sees little room left to break new ground. Even when a new area is identified, a lack of actuarial data makes it hard to price the product. "For new coverage items, the absence of historical data forces us to set loss ratios conservatively — but raising the loss ratio hurts premium competitiveness, while lowering premiums squeezes profitability," an official at one non-life insurer said. "Sometimes we decide a product is good but still don't launch it because the business case just isn't there."

Even when a new product clears development, the burden remains heavy. Under the IFRS 17 accounting regime, insurers must carefully assess the contractual service margin and long-term profitability for every coverage item they introduce. Solvency management requirements such as the K-ICS ratio have also emerged as a top priority, reinforcing a conservative culture in which companies cherry-pick only coverage items with favorable loss ratios. Financial regulators now require insurers to assume a loss ratio as high as 90 percent for new coverage items during product reviews, raising the bar high enough that the incentive to develop anything short of a highly attractive product has diminished considerably.

"Complex products rarely succeed, and even a good product won't sell if the sales commission structure and distribution muscle aren't there to support it," an official at another non-life insurer said, identifying the sales process as "the biggest bottleneck in product development."

Because these factors are unlikely to resolve quickly, the slowdown in new product development is expected to continue for now. That said, coverage areas such as senior care and mental health remain largely untapped.

"Going forward, innovation may come less from new disease coverage and more from changes in how coverage is delivered — think personalized protection or AI-linked products," one insurance industry official said. "It is worth considering what kind of regulatory support would be needed to help that shift take root."